Endogenous Immunity, Synthetic Immunity and Engineering IgM Therapeutics

Immuno-Oncology 360° – February 23-26, 2021
Bispecifics Plenary Session – February 26, 2021

Daniel S. Chen, MD, PhD, Chief Medical Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

IO360 20210226 DSC

Posted in publications.